Lifestyle-related disease in Crohn's disease: Relapse prevention by a semi-vegetarian diet

World Journal of Gastroenterology

Volumn 16, Issue 20, 2010, Pages 2484-2495

  Chiba, Mitsuro ^a   Abe, Toru ^a   Tsuda, Hidehiko ^a   Sugawara, Takeshi ^a   Tsuda, Satoko ^a   Tozawa, Haruhiko ^a   Fujiwara, Katsuhiko ^a   Imai, Hideo ^a  

^a NAKADORI GENERAL HOSPITAL   (Japan)

Author keywords

Crohn's disease; Inflammatory bowel disease; Lifestyle; Recurrence; Vegetarian diet

Indexed keywords

AZATHIOPRINE; BUDESONIDE; C REACTIVE PROTEIN; INFLIXIMAB; IRON; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PLACEBO; SALAZOSULFAPYRIDINE;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTERITIS; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPOALBUMINEMIA; HYPOCHOLESTEROLEMIA; LIFESTYLE; MAINTENANCE THERAPY; MALE; RELAPSE; REMISSION; SYMPTOMATOLOGY; VEGETARIAN DIET;

EID: 77953259387     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i20.2484     Document Type: Article

References (70)

1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407
2. Cho JH, Weaver CT. The genetics of inflammatory bowel disease. Gastroenterology 2007; 133: 1327-1339
3. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57: 1185-1191
4. Whelan G. Inflammatory bowel disease: epidemiology. In: Haubrich WS, Schaffner F, Berk JE, editors. Bockus Gastroenterology. 5th ed. Vol 2. Philadelphia: WB Saunders, 1995 1318-1325
5. Janssens AC, van Duijn CM. Genome-based prediction of common diseases: advances and prospects. Hum Mol Genet 2008; 17: R166-R173
6. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5: V1-V16
7. Travis SP, Stange EF, Lémann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006; 55 Suppl 1: i16-i35
8. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006; 130: 940-987
9. Lichtenstein GR, Hanauer SB, Sandborn WJ. Management of Crohn's disease in adults. Am J Gastroenterol 2009; 104: 465-483; quiz 464, 484
10. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernández-Sueiro JL, Balish E, Hammer RE. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359-2364
11. Sartor RB. Therapeutic manipulation of the enteric micro-flora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-1633
12. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991; 35: 238-243
13. Fabia R, Ar'Rajab A, Johansson ML, Andersson R, Willén R, Jeppsson B, Molin G, Bengmark S. Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat. Digestion 1993; 54: 248-255
14. Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997; 42: 817-822
15. Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis in inflammatory bowel disease. Gut 2004; 53: 1-4
16. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-697
17. Report of the Working Group on Arteriosclerosis of the National Heart, Lung, and Blood Institute. Arteriosclerosis, vol. 2. USDHHS, PHS, NIH 1981
18. Popkin BM. The nutrition transition in low-income countries: an emerging crisis. Nutr Rev 1994; 52: 285-298
19. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 741-745
20. Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979; 2: 762-764
21. Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, Lanfranchi GA. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 47-51
22. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52: 229-238
23. Sakamoto N, Kono S, Wakai K, Fukuda Y, Satomi M, Shi-moyama T, Inaba Y, Miyake Y, Sasaki S, Okamoto K, Kobashi G, Washio M, Yokoyama T, Date C, Tanaka H. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-163
24. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 47-52
25. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ, Stockbrügger RW. Modern life' in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998; 10: 243-249
26. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C, Chotard V, Budai B, Law L, Levy E, Seidman EG. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102: 2016-2025
27. Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan. J Clin Gastroenterol 1994; 19: 166-171
28. Morita N, Minoda T, Munekiyo M, Watanabe Y, Muto T, Yokoyama T, Tanaka H, Kawamura T, Morioka S, Hashimoto T. Case-control study of ulcerative colitis in Japan. In: Ohno Y, editor. Annual report of Research Committee on Epidemiology of Intractable Diseases, the Ministry of Health and Welfare of Japan. Nagoya: The Department of Preventive Medicine, School of Medicine, Nagoya University, 1996: 153-158 (Abstract in English)
29. Morita N, Ohnaka O, Ando S, Watanabe Y, Takazoe M, Takagi K, Yokoyama T, Tanaka H, Kawamura T, Ohno Y, Morioka S, Hashimoto T. Case-control study of Crohn's disease in Japan. In: Ohno Y, editor. Annual report of Research Committee on Epidemiology of Intractable Diseases, the Ministry of Health and Welfare of Japan. Nagoya: The Department of Preventive Medicine, School of Medicine, Nagoya University, 1997: 58-64 (Abstract in English)
30. D'Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P, Deslandres C, Morgan K, Seidman EG, Amre DK. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008; 14: 367-373
31. Hentges DJ, Maier BR, Burton GC, Flynn MA, Tsutakawa RK. Effect of a high-beef diet on the fecal bacterial flora of humans. Cancer Res 1977; 37: 568-571
32. Benno Y, Suzuki K, Suzuki K, Narisawa K, Bruce WR, Mitsuoka T. Comparison of the fecal microflora in rural Japanese and urban Canadians. Microbiol Immunol 1986; 30: 521-532
33. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309
34. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124: 1202-1209
35. Chiba M, Akashi T, Ando H, Matsuhashi T, Kato J. Three Japanese cases of inflammatory bowel disease associated with left-sided colonic diverticulosis: its implication. Inflamm Bowel Dis 2005; 11: 952-954
36. Chiba M, Sugawara T, Tsuda H, Abe T, Tokairin T, Kashima Y. Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab. Inflamm Bowel Dis 2009; 15: 1121-1122
37. Kirsner JB, Wall AJ. The medical treatment of ulcerative colitis and Crohn's disease of the colon. In: Kirsner JB, Shorter RG, editors. Inflammatory bowel disease. Philadelphia: Lea and Febiger, 1975: 279-293
38. Hirakawa H, Fukuda Y, Tanida N, Hosomi M, Shimoyama T. Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease. Gastroenterol Jpn 1993; 28: 379-384
39. Takagi S, Utsunomiya K, Kuriyama S, Yokoyama H, Taka-hashi S, Iwabuchi M, Takahashi H, Takahashi S, Kinouchi Y, Hiwatashi N, Funayama Y, Sasaki I, Tsuji I, Shimosegawa T. Effectiveness of an 'half elemental diet' as maintenance therapy for Crohn's disease: A randomized-controlled trial.Aliment Pharmacol Ther 2006; 24: 1333-1340
40. Ahn YJ, Sakanaka S, Kim MJ, Kawamura T, Fujisawa T, Mitsuoka T. Effect of green tea extract on growth of intestinal bacteria. Microb Ecol Health Dis 1990; 3: 335-338
41. Benno Y, Endo K, Miyoshi H, Okuda T, Koishi H, Mitsuoka T. Effect of rice fiber on human fecal microflora. Microbiol Immunol 1989; 33: 435-440
42. Van Loo J, Cummings J, Delzenne N, Englyst H, Franck A, Hopkins M, Kok N, Macfarlane G, Newton D, Quigley M, Roberfroid M, van Vliet T, van den Heuvel E. Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br J Nutr 1999; 81: 121-132
43. Picco MF, Bayless TM. Prognostic consideration in idiopathic inflammatory bowel disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: WB Saunders, 2000: 765-780
44. Sahmoud T, Hoctin-Boes G, Modigliani R, Bitoun A, Co-lombel JF, Soule JC, Florent C, Gendre JP, Lerebours E, Sylvester R. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut 1995; 37: 811-818
45. Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43: S85-S93
46. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979; 77: 843-846
47. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroen-terol 2002; 97: 2962-2972
48. Rutgeerts P, Hiele M, Geboes K, Peeters M, Penninckx F, Aerts R, Kerremans R. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108: 1617-1621
49. Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, Sampson L, Willett WC. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999; 69: 243-249
50. Study Group of Nutritional Element Analysis of Food. Table of nutritional element analysis of Japanese food. 5th ed. Tokyo: Ishiyaku Publishers, 2001: 12-13
51. Dwyer J. Convergence of plant-rich and plant-only diets. Am J Clin Nutr 1999; 70: 620S-622S
52. Ministry of Health, Labor, and Welfare, Japan. Dietary Reference Intakes for Japanese. Accessed October 1, 2009. Available from: URL: http://www.mhlw.go.jp/houdou/2004/11/d1/h1122-2b.pdf
53. Breslow L, Enstrom JE. Persistence of health habits and their relationship to mortality. Prev Med 1980; 9: 469-483
54. Cammà C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997; 113: 1465-1473
55. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-678
56. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Sch-reiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-1549
57. Hyams J, Crandall W, Kugathasan S, Griffths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007; 132: 863-873; quiz 1165-1166
58. Sandborn WJ, Löfberg R, Feagan BG, Hanauer SB, Campieri M, Greenberg GR. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol 2005; 100: 1780-1787
59. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE. Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 2009; 136: 441-450.e1; quiz 716
60. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, Baert F, Noman M, Vermeire S, Ternant D, Watier H, Paintaud G, Rutgeerts P. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology 2008; 134: 1861-1868
61. Boirivant M, Leoni M, Tariciotti D, Fais S, Squarcia O, Pal-lone F. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 1988; 10: 401-405
62. Jones VA, Dickinson RJ, Workman E, Wilson AJ, Freeman AH, Hunter JO. Crohn's disease: maintenance of remission by diet. Lancet 1985; 2: 177-180
63. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn's disease with an unrefined carbohydrate, fibre-rich diet. Br Med J 1979; 2: 764-766
64. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Migli-oli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-1560
65. Pearson M, Teahon K, Levi AJ, Bjarnason I. Food intolerance and Crohn's disease. Gut 1993; 34: 783-787
66. Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E. Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. Br Med J (Clin Res Ed) 1987; 295: 517-520
67. Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, Purrmann J, Fleig WE, Scheurlen C, Koop I, Pudel V, Carr L. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multi-center trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol 1996; 31: 778-785
68. Rahimi R, Nikfar S, Rahimi F, Elahi B, Derakhshani S, Vafaie M, Abdollahi M. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease. Dig Dis Sci 2008; 53: 2524-2531
69. Willett WC. Convergence of philosophy and science: the third international congress on vegetarian nutrition. Am J Clin Nutr 1999; 70: 434S-438S
70. American Institute for Cancer Research. Diet and health recommendations for cancer prevention. Accessed October 1, 2009. Available from: URL: http://www.aicr.org